NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed)
The overall goal of this program is to accelerate scientific discovery, improve research efficiency, and enhance the translation of research findings into improved health outcomes. Centers funded under this program will also foster multidisciplinary collaboration, support workforce development acros…
Closes 1 Mar 2029 (848 days)
up to USD 500,000. National Institutes of Health
Who can apply
- Where
- United States, nationwide
- Industries
- any, or not stated
- Business size
- not stated
- Amount
- up to USD 500,000
- Dates
- opens 9 Oct 2026; closes 1 Mar 2029
The funder's text has not been read for criteria yet; open the source for the full rules.
Eligibility, in the funder's words
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
About the program
The overall goal of this program is to accelerate scientific discovery, improve research efficiency, and enhance the translation of research findings into improved health outcomes. Centers funded under this program will also foster multidisciplinary collaboration, support workforce development across career stages, and promote training in emerging areas such as data science, artificial intelligence, and implementation research. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS P30 Centers Program to support integrated research Centers within its mission areas of skin biology and diseases; bone, muscle, and orthopaedic research; and rheumatic diseases. The NIAMS P30 Centers Program supports Centers that provide coordinated research infrastructure, shared resources, and methodological expertise to advance basic, translational, and clinical research. These Centers are expected to integrate state-of-the-art research resources with capabilities that support clinical and translational research, including the development, testing, and dissemination of novel analytical methods, study designs, outcome measures, and data-driven approaches.
Common questions
Am I eligible?
Only National Institutes of Health can say. The rules above are what the notice states; sign in and your business profile is compared with them line by line for a likely, maybe or unlikely verdict.
When does it close?
1 Mar 2029. Save it in your account for reminders 14, 7 and 2 days before.
Where do I apply?
On the funder's page: https://www.grants.gov/search-results-detail/359152
Is this one for you?
Sign in and your state, industry, size and turnover are compared with these rules line by line. Save it for closing reminders.